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**Page 834 (Abstract)**

**Replace** OBJECTIVE: To compare the efficacy and tolerability of a fixed combination of 0.3% gatifloxacin and 1% prednisolone (Zypred®) *versus* the individual components used separately (Zypred® and Predfort®) for infection prophylaxis and inflammation control after cataract surgery with intraocular lens implantation.

**For** OBJECTIVE: To compare the efficacy and tolerability of a fixed combination of 0.3% gatifloxacin and 1% prednisolone (Zypred®) *versus* the individual components used separately (Zymar® and Predfort®) for infection prophylaxis and inflammation control after cataract surgery with intraocular lens implantation.

**Page 835**

**Replace** The aim of this study was to compare the inflammation control and infection prophylaxis after cataract surgery provided by a fixed combination of gatifloxacin 0.3% and prednisolone acetate 1% (Zypred®, Allergan®) *versus* the individual components (Zypred® and Predfort®).

**For** The aim of this study was to compare the inflammation control and infection prophylaxis after cataract surgery provided by a fixed combination of gatifloxacin 0.3% and prednisolone acetate 1% (Zypred®, Allergan®) *versus* the individual components (Zymar® and Predfort®).
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